A Zantac lawsuit is a legal claim filed by people who developed cancer after taking Zantac and ranitidine tainted with NDMA. Zantac lawsuits seek compensation from the drug makers for cancers of the bladder, stomach, esophagus, liver, and pancreas that may have been caused by NDMA exposure.
Bladder, gastric/stomach, esophageal, liver and pancreatic
Sanofi-Aventis U.S. LLC, Sanofi US Services Inc., Chattem, Inc., Boehringer Ingelheim, Pfizer and GlaxoSmithKline
Initial stages, no trials scheduled
People must meet several prerequisites, according to Zantac lawyers, in order to be eligible for a lawsuit: documented Zantac use, a cancer diagnosis, and a link between the disease and Zantac. Lawyers are only considering claims from persons who used the brand-name Zantac, and generic ranitidine is no longer covered.
Only a lawyer can correctly evaluate a claim, as well as assist in the collection of medical documents and data needed to develop a case.
According to Zantac lawyers, several doctors who diagnosed persons with cancer after taking Zantac indicated they had no family history or genetic indications for cancer. Instead, doctors told patients that the illness was due to something in their surroundings, such as NDMA poisoning.